Clinical Trial Update: Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam [Phase 2]

View source ↗

Summary

A Phase 2 pediatric procedural sedation trial comparing rectal chloral hydrate and intranasal midazolam has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Chloral Hydrate (chloral hydrate)
• Midazolam (Midazolam)

Snippet

Sponsor: University of Sao Paulo | Conditions: Traumatic Brain Injury, Computed Tomography | Phase 2 | Status: WITHDRAWN